AOD-9604
- Research Grade
- 99% Purity
- Third-Party Verified
Availability: In stock
AOD-9604
R720,00
Growth hormone fragment — studied for fat cell metabolism and lipolytic activity
Availability: In stock
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About AOD-9604
AOD-9604 is a modified fragment of human growth hormone (residues 177–191).
How It Works in Research
Research indicates AOD-9604 mimics the way natural growth hormone regulates fat metabolism in the body. Studies show it has been observed to stimulate the breakdown of stored fat cells and inhibit new fat formation — without the effects on blood sugar or tissue growth seen with full growth hormone.
Research Applications
Fat metabolism: Studied for its ability to stimulate lipolysis (the breakdown of fat cells) and reduce lipogenesis (new fat formation) in research models. Metabolic health: Researched for its potential to support metabolic function without disrupting insulin sensitivity or promoting unwanted tissue growth.
Functional Performance Profile
Key Benefits
- Fat Metabolism Support
- Body Composition Enhancement
- Metabolic Optimization
Product Specifications
- Purity: 99.4%
- Form: Lyophilized peptide
- Storage: Lyophilized: Store at −20 °C in dry, dark conditions; stable for 1+ year
- Storage: Reconstituted: Refrigerate at 2–8 °C; use within 4–5 weeks
Research Information
- Type: Growth hormone fragment
- Pathways: Lipolysis
- Focus: Fat metabolism
Scientific Information
Research Reference Parameters — Laboratory Use Only
- Initial phase: 0.3 mg once daily, 5 days on / 2 days off
- Standard research range: 0.50 mg once daily, 5 days on / 2 days off
- Advanced research range: 1.0 mg once daily, 5 days on / 2 days off
- Research cycles typically range from 8–12 weeks
Mechanism of Action
AOD-9604 works by mimicking the lipolytic region of growth hormone. It stimulates lipolysis (the breakdown of fat) and inhibits lipogenesis (the formation of fatty acids and lipids) through beta-3 adrenergic receptor activation, without the growth-promoting effects of complete hGH.
Key Research Characteristics
Selective Fat Metabolism Targeting
AOD-9604 is a modified C-terminal fragment of human growth hormone (hGH 176–191) that retains the fat-burning properties without affecting IGF-1 levels or blood glucose regulation.
No Anabolic Effects
Unlike full-length growth hormone, AOD-9604 does not stimulate tissue growth, making it ideal for research focused purely on lipid metabolism without confounding anabolic variables.
Localized Adipose Targeting
Research suggests preferential activity in adipose tissue, particularly in stubborn fat deposits resistant to traditional interventions.
Potential Benefits in Research
Metabolic Research
- Enhanced lipolysis (fat breakdown) in research models
- Inhibition of lipogenesis (new fat formation)
- Improved body composition metrics in controlled studies
- Abdominal fat reduction without muscle mass loss
Safety Profile
- No impact on blood sugar levels in research subjects
- Does not affect insulin sensitivity markers
- No proliferative effects on tissues
- Well-tolerated in published research protocols
Research Applications
- Obesity and metabolic syndrome research
- Body composition optimization studies
- Lipid metabolism pathway investigation
- Stubborn adipose tissue research
Safety Profile
Possible Side Effects in Research
- Injection site reactions (redness, swelling, mild discomfort)
- Mild headaches in initial research phases
- Temporary water retention
- Mild joint discomfort (infrequent)
- Transient fatigue during adaptation period
Research Applications
REFERENCE RECONSTITUTION INFORMATION
This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units.
Always follow sterile preparation techniques when handling research peptides.
General Preparation
- Use bacteriostatic water (BAC water) only
- Inject water slowly down the inside of the vial
- Do not shake the vial
- Gently swirl to dissolve the peptide powder
- Store refrigerated after mixing
- Use sterile technique when handling
AOD-9604 (5mg) - RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of AOD-9604.
- Route: Subcutaneous injection
- Use sterile technique when handling and administering
- Cycle Length: 8–12 weeks (extendable to 16 weeks)
Reference Parameters (Reconstituted with 3ml BAC Water = 1.67 mg/ml)
| Dose Level | Dose (mg) | Units (mL) |
|---|---|---|
| Low | 0.30 mg | 18 units (0.18ml) |
| Medium | 0.50 mg | 30 units (0.30ml) |
| High | 1.0 mg | 60 units (0.60ml) |
Experimental Study Period
View Certificate of Analysis
Each batch of AOD-9604 is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
Related products
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.